Increased levels of sphingosine-1-phosphate in cerebrospinal fluid of patients diagnosed with tick-borne encephalitis

Journal of Neuroinflammation

Volumn 11, Issue 1, 2014, Pages

  Kułakowska, Alina ^a   Byfield, Fitzroy J ^b   Zendzian Piotrowska, Małgorzata ^a   Zajkowska, Joanna M ^a   Drozdowski, Wieslaw ^a   Mroczko, Barbara ^a   Janmey, Paul A ^b   Bucki, Robert ^a,b,c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JAN KOCHANOWSKI UNIVERSITY   (Poland)

Author keywords

Cerebrospinal fluid; FTY720P; Gelsolin; IL 6; Sphingosine 1 phosphate; Tick borne encephalitis

Indexed keywords

ALKANOLAMINE; ANTIPYRETIC AGENT; FINGOLIMOD PHOSPHATE; GELSOLIN; GLUCOCORTICOID; INTERLEUKIN 6; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ACTIN FILAMENT; ADULT; ANIMAL CELL; ARTICLE; ASTROCYTE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOSKELETON; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONOLAYER CULTURE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RAT; SIGNAL TRANSDUCTION; TICK BORNE ENCEPHALITIS; ANALOGS AND DERIVATIVES; ANIMAL; CEREBROSPINAL FLUID; DRUG EFFECTS; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANIMALS; ASTROCYTES; BIOMARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENCEPHALITIS, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; LYSOPHOSPHOLIPIDS; MALE; MIDDLE AGED; RATS; SPHINGOSINE;

EID: 84964314032     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-014-0193-4     Document Type: Article

References (45)

1. Goetzl EJ, Wang W, McGiffert C, Liao JJ, Huang MC: Sphingosine 1-phosphate as an intracellular messenger and extracellular mediator in immunity. Acta Paediatr Suppl 2007, 96:49-52.
2. Hla T: Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res 2003, 47:401-407.
3. Huang MC, Graeler M, Shankar G, Spencer J, Goetzl EJ: Lysophospholipid mediators of immunity and neoplasia. Biochim Biophys Acta 2002, 1582:161-167.
4. Konno N, Nakamura A, Ikeno Y, Cheon SH, Kitamoto K, Arioka M: Novel neurotrophic effects of sphingosylphosphorylcholine in cerebellar granule neurons and in PC12 cells. Biochem Biophys Res Commun 2007, 364:163-168.
5. Mullershausen F, Craveiro LM, Shin Y, Cortes-Cros M, Bassilana F, Osinde M, Wishart WL, Guerini D, Thallmair M, Schwab ME, Sivasankaran R, Seuwen K, Dev KK: Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. J Neurochem 2007, 102:1151-1161.
6. Osinde M, Mullershausen F, Dev KK: Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology 2007, 52:1210-1218.
7. Saini HS, Coelho RP, Goparaju SK, Jolly PS, Maceyka M, Spiegel S, Sato-Bigbee C: Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. J Neurochem 2005, 95:1298-1310.
8. Tham CS, Lin FF, Rao TS, Yu N, Webb M: Microglial activation state and lysophospholipid acid receptor expression. Int J Dev Neurosci 2003, 21:431-443.
9. Schilling T, Repp H, Richter H, Koschinski A, Heinemann U, Dreyer F, Eder C: Lysophospholipids induce membrane hyperpolarization in microglia by activation of IKCa1 Ca(2+)-dependent K(+) channels. Neuroscience 2002, 109:827-835.
10. Kimura A, Ohmori T, Ohkawa R, Madoiwa S, Mimuro J, Murakami T, Kobayashi E, Hoshino Y, Yatomi Y, Sakata Y: Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury. Stem Cells 2007, 25:115-124.
11. Coelho RP, Payne SG, Bittman R, Spiegel S, Sato-Bigbee C: The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J Pharmacol Exp Ther 2007, 323:626-635.
12. Miron VE, Jung CG, Kim HJ, Kennedy TE, Soliven B, Antel JP: FTY720 modulates human oligodendrocyte progenitor process extension and survival. Ann Neurol 2008, 63:61-71.
13. Bartke N, Hannun YA: Bioactive sphingolipids: metabolism and function. J Lipid Res 2009, 50(Suppl):S91-96.
14. Bucki R, Kulakowska A, Byfield FJ, Zendzian-Piotrowska M, Baranowski M, Marzec M, Winer JP, Ciccarelli NJ, Gorski J, Drozdowski W, Bittman R, Janmey PA: Plasma gelsolin modulates cellular response to sphingosine 1-phosphate. Am J Physiol Cell Physiol 2010, 299:C1516-1523.
15. Kulakowska A, Ciccarelli NJ, Wen Q, Mroczko B, Drozdowski W, Szmitkowski M, Janmey PA, Bucki R: Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis. BMC Neurol 2010, 10:107.
16. Zambito Marsala S, Pistacchi M, Gioulis M, Mel R, Marchini C, Francavilla E: Neurological complications of tick borne encephalitis: the experience of 89 patients studied and literature review. Neurol Sci 2014, 35:15-21.
17. Schosser R, Reichert A, Mansmann U, Unger B, Heininger U, Kaiser R: Irregular tick-borne encephalitis vaccination schedules: The effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study. Vaccine 2014, 32:2375-2381.
18. Heinz FX, Stiasny K, Holzmann H, Grgic-Vitek M, Kriz B, Essl A, Kundi M: Vaccination and tick-borne encephalitis, central Europe. Emerg Infect Dis 2013, 19:69-76.
19. Wu C, Leong SY, Moore CS, Cui QL, Gris P, Bernier LP, Johnson TA, Seguela P, Kennedy TE, Bar-Or A, Antel JP: Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation. J Neuroinflammation 2013, 10:41.
20. Sasaki H, Arai H, Cocco MJ, White SH: pH dependence of sphingosine aggregation. Biophys J 2009, 96:2727-2733.
21. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I: EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010, 17:8-16.
22. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69:292-302.
23. Min JK, Yoo HS, Lee EY, Lee WJ, Lee YM: Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Anal Biochem 2002, 303:167-175.
24. Drogemuller K, Helmuth U, Brunn A, Sakowicz-Burkiewicz M, Gutmann DH, Mueller W, Deckert M, Schluter D: Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. J Immunol 2008, 181:2683-2693.
25. Antanitus DS, Choi BH, Lapham LW: Immunofluorescence staining of astrocytes in vitro using antiserum to glial fibrillary acidic protein. Brain Res 1975, 89:363-367.
26. Kulakowska A, Zendzian-Piotrowska M, Baranowski M, Kononczuk T, Drozdowski W, Gorski J, Bucki R: Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis. Neurosci Lett 2010, 477:149-152.
27. Czupryna P, Moniuszko A, Pancewicz SA, Grygorczuk S, Kondrusik M, Zajkowska J: Tick-borne encephalitis in Poland in years 1993-2008-epidemiology and clinical presentation. A retrospective study of 687 patients. Eur J Neurol 2011, 18:673-679.
28. Mickiene A, Laiskonis A, Gunther G, Vene S, Lundkvist A, Lindquist L: Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis. Clin Infect Dis 2002, 35:650-658.
29. Schut ES, Brouwer MC, de Gans J, Florquin S, Troost D, van de Beek D: Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology 2009, 73:1988-1995.
30. Spapen H, Van Berlaer G, Moens M, Hubloue I: Adjunctive steroid treatment in acute bacterial meningitis. "To do or not to do: that is the question". Acta Clin Belg 2011, 66:42-45.
31. Min KJ, Yang MS, Kim SU, Jou I, Joe EH: Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J Neurosci 2006, 26:1880-1887.
32. Block L, Bjorklund U, Westerlund A, Jorneberg P, Biber B, Hansson E: A new concept affecting restoration of inflammation-reactive astrocytes. Neuroscience 2013, 250:536-545.
33. Pottiez G, Sevin E, Cecchelli R, Karamanos Y, Flahaut C: Actin, gelsolin and filamin-A are dynamic actors in the cytoskeleton remodelling contributing to the blood brain barrier phenotype. Proteomics 2009, 9:1207-1219.
34. Reiber H, Peter JB: Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 2001, 184:101-122.
35. Rist RJ, Romero IA, Chan MW, Couraud PO, Roux F, Abbott NJ: F-actin cytoskeleton and sucrose permeability of immortalised rat brain microvascular endothelial cell monolayers: effects of cyclic AMP and astrocytic factors. Brain Res 1997, 768:10-18.
36. Deli MA, Descamps L, Dehouck MP, Cecchelli R, Joo F, Abraham CS, Torpier G: Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neurosci Res 1995, 41:717-726.
37. Lieberman AP, Pitha PM, Shin HS, Shin ML: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci U S A 1989, 86:6348-6352.
38. Gottschall PE, Tatsuno I, Arimura A: Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res 1994, 637:197-203.
39. Kahn MA, De Vellis J: Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia 1994, 12:87-98.
40. Guptarak J, Wanchoo S, Durham-Lee J, Wu Y, Zivadinovic D, Paulucci-Holthauzen A, Nesic O: Inhibition of IL-6 signaling: a novel therapeutic approach to treating spinal cord injury pain. Pain 2013, 154:1115-1128.
41. Cui X, Liu J, Bai L, Tian J, Zhu J: Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3. Cancer Sci 2014, 105:64-71.
42. Codeluppi S, Fernandez-Zafra T, Sandor K, Kjell J, Liu Q, Abrams M, Olson L, Gray NS, Svensson CI, Uhlen P: Interleukin-6 secretion by astrocytes is dynamically regulated by PI3K-mTOR-calcium signaling. PLoS One 2014, 9:e92649.
43. Zajkowska J, Grygorczuk S, Pryszmont JM, Kondrusik M, Pancewicz S, Swierzbinska R, Hermanowska-Szpakowicz T, Klibingat M: Concentration of interleukin 6 and 10 in tick-borne and purulent encephalomeningitis. Pol Merkur Lekarski 2006, 21:29-34.
44. Palus M, Vojtiskova J, Salat J, Kopecky J, Grubhoffer L, Lipoldova M, Demant P, Ruzek D: Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system. J Neuroinflammation 2013, 10:77.
45. Kulakowska A, Zajkowska JM, Ciccarelli NJ, Mroczko B, Drozdowski W, Bucki R: Depletion of plasma gelsolin in patients with tick-borne encephalitis and Lyme neuroborreliosis. Neurodegener Dis 2011, 8:375-380.